Is DUSA a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

207 people get DUSA articles and Market Currents by email alert.

Get email alerts on DUSA »

HEADLINES:

Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer

GlobeNewswire (Dec 5, 2012)
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.

GlobeNewswire (Nov 8, 2012)
The Over/Under 'Value' Stock Shootout
Erick McKitterick • Mon, Nov 5, 2012 • 5 Comments
DUSA Pharmaceuticals, Inc.(R) to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

GlobeNewswire (Nov 5, 2012)
7 Reasons To Buy This Cheap $5.50 Drug Play
Bret Jensen • Thu, Sep 13, 2012 • 10 Comments
DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study

GlobeNewswire (Sep 13, 2012)
5 Highly-Liquid Healthcare Stocks With Growth On The Horizon
ZetaKap • Wed, Sep 12, 2012 • 1 Comment
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference

GlobeNewswire (Sep 4, 2012)
5 Profitable Healthcare Stocks Preferred By Analysts
ZetaKap • Thu, Aug 16, 2012 • 12 Comments
6 Highly Profitable Healthcare Stocks With Plenty Of Cash
ZetaKap • Fri, Aug 3, 2012
DUSA's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Aug 2, 2012
DUSA Pharmaceuticals Reports Second Quarter 2012 Corporate Highlights and Financial Results

GlobeNewswire (Aug 2, 2012)
DUSA Pharmaceuticals, Inc.(R) to Host Second Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

GlobeNewswire (Jul 26, 2012)
5 Undervalued Healthcare Stocks Being Snapped Up By Hedge Funds
Kapitall • Tue, Jul 24, 2012 • 1 Comment
5 High-Growth Healthcare Stocks Fueled By Large Cash Reserves
ZetaKap • Tue, Jul 10, 2012 • 1 Comment
The Many Hidden Costs Of Active Investing In Small Caps
Kurtis Hemmerling • Thu, Jun 21, 2012 • 2 Comments
DUSA Pharmaceuticals to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City

GlobeNewswire (Jun 15, 2012)
DUSA Pharmaceuticals, Inc.(R) to Webcast Annual Meeting of Shareholders

GlobeNewswire (Jun 7, 2012)
DUSA Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

GlobeNewswire (May 31, 2012)
7 Undervalued Healthcare Stocks Being Bought Up By Hedge Funds
Kapitall • Tue, May 22, 2012 • 1 Comment

To learn more about Seeking Alpha Pro, click here.

7 Reasons To Buy This Cheap $5.50 Drug Play
Bret Jensen • Thu, Sep 13, 2012 • 10 Comments
Shedding A Little Light On Under-Followed DUSA Pharmaceuticals
Stephen Simpson • Mon, Apr 16, 2012
DUSA Pharmaceuticals, Up 25% Tuesday, Still Has Room To Run
Analytical Chemist • Wed, Mar 7, 2012
DUSA Pharmaceuticals Is A Small Gem
Jim Van Meerten • Fri, Dec 23, 2011 • 4 Comments
DUSA Pharmaceuticals Shares Tumble After Earnings: Low Growth Ahead?
Steven Breazzano • Fri, Nov 11, 2011 • 11 Comments
DUSA Pharmaceuticals: Recent Pullback Provides Attractive Entry Point
Steven Breazzano • Tue, May 10, 2011 • 23 Comments
Dermatologists Take Note of DUSA's Skin Cancer Treatment
Ian Wyatt • Sun, May 8, 2011 • 11 Comments
DUSA: A Pharmaceutical With Profits Now and Strong Growth Ahead
Analytical Chemist • Mon, Apr 11, 2011 • 29 Comments
DUSA Pharmaceuticals: Small-Cap Biotech With a Healthy Cash Flow
Steven Breazzano • Mon, Mar 14, 2011 • 2 Comments
DUSA Pharmaceuticals: A Growth Stock That Looks Like a Value Stock
Manish Babla • Fri, Mar 4, 2011 • 7 Comments
Why DUSA's Last Quarter Was Much Stronger Than It Initially Appeared to Be
Logical Thought • Mon, Nov 8, 2010 • 6 Comments
DUSA: A Great Value in Micro Cap Biotech
Logical Thought • Thu, Aug 26, 2010 • 3 Comments

The Over/Under 'Value' Stock Shootout
Erick McKitterick • Mon, Nov 5, 2012 • 5 Comments
5 Highly-Liquid Healthcare Stocks With Growth On The Horizon
ZetaKap • Wed, Sep 12, 2012 • 1 Comment
5 Profitable Healthcare Stocks Preferred By Analysts
ZetaKap • Thu, Aug 16, 2012 • 12 Comments
6 Highly Profitable Healthcare Stocks With Plenty Of Cash
ZetaKap • Fri, Aug 3, 2012
5 Undervalued Healthcare Stocks Being Snapped Up By Hedge Funds
Kapitall • Tue, Jul 24, 2012 • 1 Comment
5 High-Growth Healthcare Stocks Fueled By Large Cash Reserves
ZetaKap • Tue, Jul 10, 2012 • 1 Comment
The Many Hidden Costs Of Active Investing In Small Caps
Kurtis Hemmerling • Thu, Jun 21, 2012 • 2 Comments
7 Undervalued Healthcare Stocks Being Bought Up By Hedge Funds
Kapitall • Tue, May 22, 2012 • 1 Comment
Top 10 Stocks With Strong Balance Sheet And Price Performance In 2012
StockPandit • Fri, Apr 27, 2012
5 Undervalued Healthcare Stocks With Positive Receivables Trends
Kapitall • Thu, Apr 12, 2012
3 Hot Pharmas With Skin In The Game
Stanley Barton • Mon, Mar 19, 2012 • 4 Comments
Potential Trades For The Week Of Jan. 30: Looking For Consolidation
Michael Kudrna • Tue, Jan 31, 2012
30 Stocks Expected To Beat The S&P By 5 Points
Insider Monkey • Mon, Jan 9, 2012 • 3 Comments
5 High Quality Companies To Buy, 4 To Avoid
Paulo Santos • Mon, Dec 5, 2011 • 27 Comments
20 Smart Money Stock Picks Trading Under $5
Kapitall • Thu, Nov 3, 2011 • 4 Comments
10 Medical Device Companies With Plenty of Upside
Inflection Point Investing LLC • Mon, Apr 18, 2011 • 2 Comments
19 Undervalued Micro Caps With EPS Growth of Over 50% for 2011-12
Rash Menaria • Wed, Apr 6, 2011 • 3 Comments
52 Stocks Worth Watching That Hit 52 Week Highs Last Friday
Scott's Investments • Mon, Apr 4, 2011
31 Stocks Worth Watching That Hit 52 Week Highs on Friday
Scott's Investments • Mon, Mar 28, 2011
Slow Growth May Offer Comfort - And Crush Shorts
Logical Thought • Mon, Sep 27, 2010 • 16 Comments

DUSA's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Aug 2, 2012

Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer

GlobeNewswire (Dec 5, 2012)
Movers & Shakers: Thursday’s biggest movers; Apple at 5-month low

at MarketWatch.com (Nov 8, 2012)
Midday Movers: AMCX, DDS, KORS & More

at CNBC.com (Nov 8, 2012)
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.

GlobeNewswire (Nov 8, 2012)
DUSA Pharmaceuticals, Inc.(R) to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

GlobeNewswire (Nov 5, 2012)
DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study

GlobeNewswire (Sep 13, 2012)
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference

GlobeNewswire (Sep 4, 2012)
DUSA Pharmaceuticals Reports Second Quarter 2012 Corporate Highlights and Financial Results

GlobeNewswire (Aug 2, 2012)
DUSA Pharmaceuticals, Inc.(R) to Host Second Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

GlobeNewswire (Jul 26, 2012)
DUSA Pharmaceuticals to Present at the Inaugural Marcum MicroCap Conference on June 20th in New York City

GlobeNewswire (Jun 15, 2012)
DUSA Pharmaceuticals, Inc.(R) to Webcast Annual Meeting of Shareholders

GlobeNewswire (Jun 7, 2012)
DUSA Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

GlobeNewswire (May 31, 2012)
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results

GlobeNewswire (May 8, 2012)
DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call

GlobeNewswire (May 1, 2012)
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R) Kerastick(R) Photodynamic Therapy

GlobeNewswire (Apr 24, 2012)
DUSA Pharmaceuticals Introduces Teeing Off Against Sun Damage(TM) Campaign to Raise Awareness of Actinic Keratosis

GlobeNewswire (Apr 10, 2012)
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference

GlobeNewswire (Mar 23, 2012)
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference

GlobeNewswire (Mar 19, 2012)
DUSA Pharmaceuticals Introduces "Spot Signs of AK" Campaign to Raise Awareness of a Common Precancerous Skin Condition - Actinic Keratosis

GlobeNewswire (Mar 16, 2012)
Earnings Watch: Updates, advisories and surprises

at MarketWatch.com (Mar 6, 2012)

DUSA vs. ETF Alternatives

Company Description

DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan®... More

Sector: Healthcare

Industry: Drug Manufacturers - Other

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, December 14, 2012, 4:35 PM Dusa Pharmaceuticals (DUSA) reports preliminary results of Phase II clinical trials investigating the use of the Levulan Kerastick in conjunction with BLU-U blue light illumination for the treatment of actinic keratoses of the face and scalp when utilizing short drug incubation. The study demonstrated that treatment — after incubating for one, two or three hours — resulted in a statistically significant number of patients with complete lesion clearance and a statistically significant reduction in AK lesion count. Comment! [Healthcare]
Thursday, November 8, 2012, 12:45 PM Midday top 10 gainers: DUSA +38%. PRMW +23%. ARX +22%. RST +22%. ES +19%. FALC +18%. UPIP +18%. SAPE +17%. PRSC +17%. MWW +17%. Midday top 10 Losers: CPRX -62%. BCRX -39%. COBR -24%. PRSS -21%. CALI -21%. UPG -20%. SVNT -19%. TRU -19%. MITK -19%. PANL -18%. Comment!
Thursday, November 8, 2012, 9:16 AM DUSA Pharmaceuticals (DUSA) +37.7% premarket after agreeing to be acquired by India's Sun Pharma for $8/share, giving the deal a total cash value of ~$230M. The price represents a 38% premium to DUSA's closing price yesterday. Dermatology company DUSA develops and markets the Levulan photodynamic therapy platform for the face and scalp. 1 Comment [Healthcare, M&A, On the Move]
Thursday, November 8, 2012, 9:10 AM Premarket gainers: DUSA +38%. MTSL +28%. USAT +15%. WLL +11%. ITMN +11%. SD +9%. QCOM +9%. THQI +8%. EZCH +7%. ALU +6%. MWW +7%. TTM +6%. DF +5%.
Losers: CPRX -56%. BCRX -34%. PANL -25%. SVNT -19%. SGEN -11%. MNST -10%. CNQR -9%. TNK -9%. NBG -8%. PSTI -8%. MAKO -7%. WINI -6%. AUI -5%. Comment! [On the Move]
Thursday, September 13, 2012, 9:32 AM Dusa Pharmaceuticals' (DUSA) Levulan treatment for the skin condition actinic keratoses performs well in Phase 2 trials. Often called "sun spots," actinic keratoses are scaly patches on the skin caused by excessive exposure to ultraviolet light and can lead to cancer. Shares +4.3% but were much higher premarket. (PR) Comment! [Healthcare, On the Move]
Thursday, August 2, 2012, 6:41 AM DUSA Pharmaceuticals (DUSA): Q2 EPS of $0.06 misses by $0.01. Revenue of $11.7M (+20.6% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Tuesday, May 8, 2012, 6:45 AM DUSA Pharmaceuticals (DUSA): Q1 EPS of $0.08 misses by $0.01. Revenue of $13.4M (+21.8% Y/Y) beats by $0.4M. (PR) Comment! [Earnings, Healthcare]
Tuesday, March 6, 2012, 6:41 AM DUSA Pharmaceuticals (DUSA): Q4 EPS of $0.13 in-line. Revenue of $15.3M (+28.6% Y/Y) beats by $1.5M. (PR) Comment! [Earnings, Healthcare]

Asif Suria
New Post: Merger Arbitrage Mondays http://bit.ly/st1w3P $HUM $KBW $FCAL $DUSA $KYAK
11/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
5 Highly-Liquid Healthcare Stocks With Growth On The Horizon http://bit.ly/OqsvnM $CORT $CPIX $DNDN $DUSA $PMTI @ZetaKap
9/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
5 Profitable Healthcare Stocks Preferred By Analysts http://bit.ly/R3SeBs $BDSI $DUSA $HLF $IMMU $QCOR @ZetaKap
8/16/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
6 Highly Profitable Healthcare Stocks With Plenty Of Cash http://bit.ly/MmVqsf $OSIR $DUSA $ICUI $THOR $SIGA $ATRI @ZetaKap
8/3/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
5 High-Growth Healthcare Stocks Fueled By Large Cash Reserves http://bit.ly/MhSY2c $DNDN $DUSA $PMTI $VOLC $ZLTQ @ZetaKap
7/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
DUSA - 64% Barchart technical sell signal - 23.56% off its 1 year high - Relative Strength Index 39.50%
6/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
3/16 Video Watchlist $ANR $SCHS $HNR $SSW $ACAS $KCG $DUSA $ANW $VVUS $SWHC $ELY $YNDX $VRS $ARTC http://bit.ly/ylL6fK
3/16/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Kudrna
Potential Trades This Week: Looking For Consolidation $IRDM $DUSA $MDCO $SPY $IWM $DIA $QQQ $TBT $TLT #KSMT http://bit.ly/z24CU1
1/31/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
DUSA - Up 18 time and38.25% in the last month
12/23/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Kudrna
new 52-week high in $DUSA on a quick surge of volume
4/20/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

DUSA DUSA Pharmaceuticals, Inc.

DUSA

DUSA Pharmaceuticals, Inc.